Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

MLA

Park, Jihyun, et al. “Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.” Nuclear Medicine and Molecular Imaging, vol. 48, no. 4, Dec. 2014, pp. 295–302. EBSCOhost, https://doi.org/10.1007/s13139-014-0289-x.

APA

Park, J., Chang, K. J., Seo, Y. S., Byun, B. H., Choi, J. H., Moon, H., Lim, I., Kim, B. I., Choi, C. W., & Lim, S. M. (2014). Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Nuclear Medicine and Molecular Imaging, 48(4), 295–302. https://doi.org/10.1007/s13139-014-0289-x

Chicago

Park, Jihyun, Kyoung Jin Chang, Young Seok Seo, Byung Hyun Byun, Joon Ho Choi, Hansol Moon, Ilhan Lim, Byung Il Kim, Chang Woon Choi, and Sang Moo Lim. 2014. “Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.” Nuclear Medicine and Molecular Imaging 48 (4): 295–302. doi:10.1007/s13139-014-0289-x.